First was the renewal of the Memorandum of Understanding with the Ministry of Health Malaysia to provide free radiotherapy and radiosurgery treatment for an additional 500 patients from government hospitals. These patients, referred by MOH and its specialists, will receive treatment at seven of IHH Malaysia’s hospitals, equipped with Gamma Knife and Linear Accelerator (LINAC). Since 2022, IHH Malaysia has completed treatment for 500 cancer patients using these cutting-edge technologies in the previous iteration of the MOU.

“At IHH Healthcare, we believe that public-private partnerships are crucial in ensuring a more equitable healthcare ecosystem for all. The renewal of our partnership with the Ministry of Health is testament to our commitment to support Malaysia’s national healthcare agenda while giving back to our community,” said IHH Chairman Tan Sri Mohammed Azlan bin Hashim.

“Reducing the burden of cancer is one of the priorities we have set for ourselves, as part of our global sustainability goals to touch 5 million lives for healthier communities by next year. We are gratified that our Life Renewed corporate responsibility programme has given a new lease of life to many patients since its inception. It is our privilege to share our clinical and care capabilities and resources to provide quality treatment for the underserved in Malaysia, as we journey on to provide Care. For Good.,” said IHH Group CEO Dr Prem Kumar Nair. 

“In 2022, we approached the Ministry of Health Malaysia to collaborate and launch the Life Renewed cancer treatment corporate responsibility initiative for 500 patients from government hospitals. Our key consideration on the type of treatment offered was based on what were the most pressing healthcare needs of the population and what would make the most impact to our community. After reviewing the effectiveness of the programme, we are delighted to renew the MOU to provide radiotherapy and radiosurgery treatment for another 500 cancer patients starting from 1 March 2024, delivering our purpose to touch lives and transform care,” said IHH Malaysia CEO Jean-François Naa. 

Next, Gleneagles Hospital Kuala Lumpur launched the Emergen-Sync project, integrating the PERTAMA ePCR system, to deliver highly responsive Accident & Emergency services to our patients. The PERTAMA system’s real time data access allows immediate access to critical patient information, ensuring seamless coordination between emergency medical teams and hospital staff.

"The launch of Emergen-Sync with the PERTAMA ePCR system is another important step in our journey to provide quality patient care, especially during accidents and emergencies, where speed and efficiency are critical for a patient’s survival. The real-time data access to critical patient information enables swift decision-making and ultimately improves patient outcomes,” explained Hoo Ling Lee, CEO of Gleneagles Hospital Kuala Lumpur.

The extensive three-month pilot programme, initiated in October 2023, has met expectations and established a benchmark for efficiency and quality in emergency medical care.